Zachary Hornby serves as the Chief Executive Officer and President of Boundless Bio, Inc., where he leverages his extensive experience in the biotechnology sector to lead the company in its mission to revolutionize cancer treatment. Under his stewardship, Boundless Bio has made significant strides in...
Zachary Hornby serves as the Chief Executive Officer and President of Boundless Bio, Inc., where he leverages his extensive experience in the biotechnology sector to lead the company in its mission to revolutionize cancer treatment. Under his stewardship, Boundless Bio has made significant strides in addressing the challenges posed by extrachromosomal DNA (ecDNA) in cancer cells. This innovative approach targets the unbound and unwound DNA that allows cancer cells to proliferate and develop resistance to therapies, positioning the company at the forefront of cancer research and treatment.
With a robust clinical pipeline and a commitment to international development capabilities, Hornby has successfully guided Boundless Bio from its inception to a publicly traded entity, culminating in a remarkable $1.7 billion acquisition by Roche. His leadership is characterized by a deep understanding of new product planning, drug development, and biopharmaceuticals, which has been instrumental in navigating the complexities of the pharmaceutical industry. Hornby’s strategic vision has not only fostered a culture of boundless innovation and energy within the organization but has also attracted top-tier talent and investment.
Key projects under his direction include the advancement of novel therapies that specifically target ecDNA-driven oncogenes, which have the potential to transform treatment paradigms for various cancers. His expertise in new business development and forecasting has enabled Boundless Bio to identify and capitalize on emerging opportunities in the life sciences sector, ensuring sustainable growth and impactful contributions to patient care. As a seasoned biotechnology executive, Zachary Hornby continues to drive Boundless Bio’s mission forward, making significant contributions to the fight against cancer.
